AAN 2021: Diroximel Fumarate Slows Brain Volume Loss to Normal Levels in Relapsing–Remitting Multiple Sclerosis
Findings are in line with low reported rates of disease progression
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.